Jean-Michel Longpré Selected Research

eglin proteinase inhibitors (eglin C)

4/2006

Inhibition of human matriptase by eglin c variants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Michel Longpré Research Topics

Disease

14	Pain (Aches) 09/2021 - 03/2014
7	Hypothermia 01/2021 - 01/2017
7	Neoplasms (Cancer) 12/2020 - 04/2006
6	Hypotension (Low Blood Pressure) 01/2021 - 03/2015
5	Chronic Pain 01/2021 - 03/2014
3	Asthma (Bronchial Asthma) 12/2020 - 10/2019
2	Hypersensitivity (Allergy) 03/2021 - 12/2019
2	Arthritis (Polyarthritis) 03/2021 - 05/2009
2	Hypertension (High Blood Pressure) 01/2021 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 10/2019
2	Constipation 09/2020 - 04/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2019
1	Neuroinflammatory Diseases 03/2021
1	Neurogenic Inflammation 03/2021
1	Edema (Dropsy) 03/2021
1	Inflammation (Inflammations) 03/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Hypertrophy 01/2021
1	Uveal melanoma 12/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2020
1	Stroke (Strokes) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Breast Neoplasms (Breast Cancer) 12/2019
1	Gliosis 12/2019
1	Central Nervous System Diseases (CNS Diseases) 12/2019
1	Brain Injuries (Brain Injury) 12/2019
1	Allergic Rhinitis 10/2019
1	Respiratory Insufficiency (Respiratory Failure) 04/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2018
1	Diabetes Complications 11/2018
1	Heart Failure 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Bone Neoplasms (Bone Cancer) 03/2014
1	Osteoarthritis 05/2009

Drug/Important Bio-Agent (IBA)

8	NeurotensinIBA 01/2021 - 01/2017
7	Analgesics (Analgesic Drugs)IBA 09/2021 - 03/2014
6	Formaldehyde (Formol)FDA Link 03/2021 - 03/2014
4	Opioid Analgesics (Opioids)IBA 01/2021 - 04/2019
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021 - 06/2017
3	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 12/2020 - 10/2019
3	Morphine (MS Contin)FDA LinkGeneric 09/2020 - 04/2019
2	Freund's AdjuvantIBA 01/2020 - 01/2016
2	neurotensin (9-13)IBA 01/2020 - 11/2019
2	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2020 - 01/2016
1	INCB3344IBA 03/2021
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2021
1	Therapeutic UsesIBA 01/2021
1	apelin-13 peptideIBA 01/2021
1	SaltsIBA 01/2021
1	cysteinyl-leukotrieneIBA 12/2020
1	Naloxone (Narcan)FDA LinkGeneric 09/2020
1	AminesIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	nabilone (Cesamet)FDA Link 12/2019
1	Zoledronic Acid (Zometa)FDA Link 12/2019
1	Phenobarbital (Luminal)FDA Link 12/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2019
1	Tyrosine (L-Tyrosine)FDA Link 11/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2019
1	Charcoal (Charbon)IBA 04/2019
1	FructoseIBA 11/2018
1	Streptozocin (Streptozotocin)FDA Link 11/2018
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Chemokine ReceptorsIBA 01/2016
1	LigandsIBA 03/2015
1	Amino Acids FDA Link 03/2015
1	ANG2002IBA 03/2014
1	Metalloproteases (Metalloproteinases)IBA 05/2009
1	Enzyme Precursors (Zymogens)IBA 05/2009
1	ADAMTS ProteinsIBA 05/2009
1	Serine Proteases (Serine Protease)IBA 04/2006
1	eglin proteinase inhibitors (eglin C)IBA 04/2006
1	matriptaseIBA 04/2006
1	EnzymesIBA 04/2006
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2006

Therapy/Procedure

8	Analgesia 01/2021 - 03/2014
2	Therapeutics 12/2020 - 12/2019
2	Pain Management 02/2020 - 12/2019
2	Intravenous Administration 11/2019 - 04/2019
1	Radiotherapy 01/2020
1	Induced Hypothermia 01/2020
1	Aftercare (After-Treatment) 01/2020